SBIR-STTR Award

A 3-D Robot Design to Overcome Arm Dysfunction in Stroke
Award last edited on: 4/19/19

Sponsored Program
STTR
Awarding Agency
NIH : NICHD
Total Award Amount
$847,023
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Julius P Dewald

Company Information

Lam Design Management LLC

82 Stonehenge Drive
Orchard Park, NY 14127
   (716) 539-5764
   wim.lam@lam-dm.com
   www.lam-dm.com

Research Institution

Northwestern University

Phase I

Contract Number: 1R41HD049923-01
Start Date: 8/1/05    Completed: 6/30/09
Phase I year
2005
Phase I Amount
$100,000
Disturbances in movement coordination are the least well understood but often the most debilitating with respect to functional recovery following stroke. These deficits in coordination are expressed in the form of abnormal muscle synergies and result in limited and stereotypic movement patterns that are functionally disabling. The result of these constraints in muscle synergies is an abnormal coupling between shoulder abduction and elbow flexion, which significantly reduces a stroke survivor's reaching space when he/she lifts the weight of the impaired arm against gravity. Current neurotherapeutic approaches to mitigate these abnormal synergies have produced, at best, limited functional recovery. In an effort to remediate this shortcoming the current project proposes to fully develop and examine the effectiveness of a novel 3-D force controlled robot arm that allows persons with stroke to progressively overcome the negative effects of the weight of their limb during functional movements. The specific objective of this development project is to adapt a 3-D force controlled robot arm, the HaptfcMASTER (HM), to a Biodex System 3 seating system and integrate it with a compact real-time 3-D visual display to generate an upper extremity rehabilitation device that implements a virtual mechanical environment. There is a current deficiency in rehabilitation science calling for a device that has the capacity to both accurately evaluate and deliver highly controlled patient-specific upper extremity rehabilitation. Development of the Arm Coordination Training 3-D device (ACT3D) for the measurement and rehabilitation of stroke-induced movement discoordination realizes this need. The device will provide high-resolution measurements of physiological (strength and coordination) and functional performance (reaching workspace) evaluating the effectiveness of rehabilitation interventions. Therefore, quantitative outcome measures will be obtained and may be used to evaluate patient progress. The device will also be designed to deliver novel interventions that train individuals with a broad spectrum of upper extremity reaching impairment to progressively overcome the negative effects of gravity. Furthermore, the ACT3D will be developed to emulate real live scenarios such as reaching and retrieval of objects of different weight in space. The device will interface with the user in a safe and comfortable fashion quickly setup by a healthcare provider. It is anticipated that the ACT3D will directly benefit a large number of individuals who currently suffer from the disabling effects of stroke

Phase II

Contract Number: 2R42HD049923-02
Start Date: 8/1/05    Completed: 4/30/09
Phase II year
2007
(last award dollars: 2008)
Phase II Amount
$747,023

Disturbances in movement coordination are the least well understood but often the most debilitating with respect to functional recovery following stroke. These deficits in coordination are expressed in the form of abnormal muscle synergies and result in limited and stereotypic movement patterns that are functionally disabling. The result of these constraints in muscle synergies is an abnormal coupling between shoulder abduction and elbow flexion, which significantly reduces reaching range of motion or workspace when an individual with stroke lifts the weight of the impaired arm against gravity. In Phase I of this STTR the first prototype of the Arm Coordination Training 3-D system (ACT3D) was developed and tested. It consists of a force controlled robot combined with a Biodex System 3 seating system and a compact LCD visual display. As part of Phase I, it was demonstrated that the ACT3D could be used to completely eliminate the weight of the arm or provide partial support of the limb during active reaching. It was also demonstrated that individuals with chronic stroke can be trained to overcome gravity-induced discoordination subsequently increasing the workspace of the paretic arm. During Phase II of this STTR, the results obtained in Phase I will be expanded upon by developing and building a greatly improved commercial product. The commercial ACT3D system will have an increased motion range, reduced inertial effects as experienced by the individual with stroke, and increased safety features compared with the original prototype (aim 1). Furthermore, it will offer intuitive user- friendly software that conforms to clinical demands (aim 2). Finally, the performance of the commercial system will be tested for an expanded set of training and strengthening tasks that include reaching movements in several planes, in the presence of inertial or viscous loads and under isokinetic or velocity-controlled constraints (aim 3). The performance of the system will be monitored simultaneously for its ease of use, overall safety, perceived inertial effects, and effectiveness of the visual feedback system. The commercial ACT3D system will be designed to provide high-resolution measurements of physiological (strength and coordination) and functional (reaching workspace) performance that can be readily employed in assessing the effectiveness of rehabilitation interventions. Additionally, the commercial ACT3D system will be designed for the implementation of novel rehabilitation interventions that are expected to increase the functional reaching abilities of individuals with stroke. Finally, the envisioned system will be a safe and relatively compact intervention/measurement device that can be easily deployed even in the smallest clinics. The marketing and sales of the proposed ACT3D system (Phase III of this project) will be realized by a consortium consisting of Lam Design Management LLC, Northwestern University, Biodex Medical Systems and Hocoma, Inc. 7. Project Narrative The commercial ACT3D system will be designed to provide high-resolution measurements of physiological (strength and coordination) and functional (reaching workspace) performance that can be readily employed in assessing the effectiveness of rehabilitation interventions. Additionally, the commercial ACT3D system will be designed for the implementation of novel rehabilitation interventions that are expected to increase the functional reaching abilities of individuals with stroke. Finally, the envisioned system will be a safe and relatively compact intervention/measurement device that can be easily deployed even in the smallest clinics.

Thesaurus Terms:
There Are No Thesaurus Terms On File For This Project.